Pharma

Dec 27 2017

Clinical News News, Page 1 – Pharmaceutical Technology #pharmaceutical #industry #profile

#pharmaceutical companies news # Clinical News – Page 1 Stay up to date with the latest Clinical News updates from the global pharmaceutical industry Latest Clinical News Update Pfizer, DCRI and partners collaborate to improve adult vaccination rates 02 September, 2016 Pfizer, Duke Clinical Research Institute (DCRI), Duke Primary Care, and Premier have collaborated to work together to improve adult vaccination rates within a primary care. read more Sunovion to acquire Canada’s Cynapsus Therapeutics for $624m Friday, September 02, 2016 Sunovion Pharmaceuticals has signed an agreement to acquire Canadian-based Cynapsus Therapeutics for. New report says age and general wellbeing can …

Dec 25 2017

DSM says plans to cut 1, 100 jobs prompted by recent pharma moves not shareholder pressure #biotech #pharma

#dsm pharma # DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure By Gareth MacDonald+ Gareth MACDONALD 25-Aug-2015 2015-08-25T00:00:00Z Last updated on 26-Aug-2015 at 13:46 GMT 2015-08-26T13:46:47Z Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon. The Dutch supplier announced the job cuts today, explaining that the move will save it €125m to €150m ($144m to $173m) over the next two years. DSM said around half of the job cuts will be at …

Dec 19 2017

Global pharma sales to reach $1 #dragon #pharma

#pharmaceutical market size # Global pharma sales to reach $1.3 trillion The 2015 CMR Pharmaceutical R D Factbook reveals a surge in global sales – reaching a milestone of $1 trillion in 2014 – and forecasts continued growth with the expectation of sales reaching $1.3 trillion by 2018. The pharmaceutical market is not in an “Era of Scarcity” as some analysts describe the Pharma R D environment post-2005. Industry data challenges negative perceptions and demonstrates the pharma industry’s continued commitment to creating and employing innovative solutions to tackle its largest hurdles. Key highlights from the 2015 Factbook include: Diversification is …

Dec 8 2017

Customer Reviews: Herb Pharm – Pharma Kava Extract 1 oz Health and Beauty #ivax #pharma

#pharma kava # Customer Reviews This is my favorite of all the kava kava supplies I’ve found. If you’re prone to anxiety or even find yourself infrequently in situations that make you anxious this extract could be a great ally. It’s extremely helpful when dealing with uncomfortable emotions, such as anger. I find it’s effect to be almost immediate. Herbal remedies just don’t work the same way on everyone. Do not use this extract if you’re expecting some kind of buzz. I’m sure there are other substances on this planet for that. Ditto if you are Judy Garland or someone …

Dec 7 2017

Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #forest #pharma

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …

Dec 1 2017

Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 #pharma #world

#lupin pharma # Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 Sohini Das | Ahmedabad Jan 19, 2016 10:01 AM IST Looking to add $1 billion in revenues from inorganic growth to reach its target turnover of $5 billion by 2018, pharma giant Lupin, which is currently worth $2 billion, says it is open to late stage speciality assets. Lupin s chief financial officer Ramesh Swaminathan told Business Standard that while $200-300 million per acquisition is a sweet spot for the company historically, it does not mean that the company won t look at bigger acquisitions. …

Nov 29 2017

Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout #biotechnology #industry

#onyx pharma # Onyx Pharma CEO Turns $1 Billion Into $10 Billion With Amgen Takeout SOUTH SAN FRANCISCO, Calif. ( TheStreet ) — Every biotech CEO wants to say they bought an asset for X and sold it for 10X, yet few top executives manage to create value on this mammoth scale. Onyx Pharmaceuticals’ ( ONXX ) CEO Tony Coles just did it. The 10X is Amgen ( AMGN ) paying $10 billion in cash ($125 per share) to acquire Onyx. The deal, much discussed and analyzed since June, was finally announced Sunday night. But Amgen wouldn’t be buying Onyx …

Nov 26 2017

Companies and Markets News, Page 1 – Pharmaceutical Technology #pharma #business #development

#pharmaceutical companies news # Companies and Markets – Page 1 Stay up to date with the latest Companies and Markets updates from the global pharmaceutical industry Latest Companies and Markets Update M read more Deals this week: Elite Pharmaceuticals, Orexigen Therapeutics, LegoChem Biosciences Friday, September 02, 2016 Elite Pharmaceuticals and SunGen Pharma LLC have entered a development and licensing agreement for four generic pharmaceutical. Report: Global diabetes and obesity therapeutics market to double by 2022 Friday, September 02, 2016 The global market for diabetes mellitus and obesity is forecast to increase from $70.8bn in 2015 to $163.2bn by 2022, according …

Nov 23 2017

DSM says plans to cut 1, 100 jobs prompted by recent pharma moves not shareholder pressure #euro #pharma

#dsm pharma # DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure By Gareth MacDonald+ Gareth MACDONALD 25-Aug-2015 2015-08-25T00:00:00Z Last updated on 26-Aug-2015 at 13:46 GMT 2015-08-26T13:46:47Z Royal DSM will make up to 1100 staff redundant by the end of 2017 to cut costs following the formation of its Sinochem JV and pharma products deal with Patheon. The Dutch supplier announced the job cuts today, explaining that the move will save it €125m to €150m ($144m to $173m) over the next two years. DSM said around half of the job cuts will be at …

Nov 21 2017

Pharmaceutical company promises 1, 500 new jobs for Georgia – CBS46 News #pharma #d

#pharmaceutical company jobs # Pharmaceutical company promises 1,500 new jobs for Georgia It s lunchtime at the Blue Willow Inn and business is booming. It hasn t always been this good. The restaurant fell into bankruptcy three years ago. But better times soon could be ahead when a pharmaceutical company opens up a manufacturing plant a few miles away which could bring in more than 1,500 new workers. Billie Van Dyke, who owns Blue Willow, hopes she gets her slice of the economic pie when Baxter International moves in. “That means my business is going to increase also,” Van Dyke …